SUMMARY The electrophysiological characteristics of demyelinated axons are sensitive to changes in plasma calcium concentration. This study investigated the effect of verapamil, a calcium antagonist drug, on brainstem auditory, visual, and somatosensory evoked potentials in multiple sclerosis patients. Eight clinically stable patients with abnormal visual and/or brainstem auditory evoked potentials and four normal volunteers were studied. During intravenous infusions of verapamil (mean plasma concentration = 130-0 + 56 4 ng/ml), the latencies of peaks III and V were shortened (p < 0.05) in multiple sclerosis patients with abnormally prolonged BAEPs. The I-III (AL = 0-08 ms), III-V (A = 0-46 ms), and I-V (A = 0-53 ms) interpeak intervals, and the
I-III (AL = 0-08 ms), III-V (A = 0-46 ms), and I-V (A = 0-53 ms) interpeak intervals, and the P100 latency (A = 10-15 ms) of the visual evoked potential were similarly affected in these patients. In contrast, normal evoked potentials of both multiple sclerosis patients and control subjects were not altered compared to baseline recordings obtained 24 hours earlier. Intravenous verapamil, therefore, alters the BAEPs and VEPs of some multiple sclerosis patients with demyelinated auditory and visual pathways by shortening pathologically prolonged latencies toward normal. The present study suggests pharmacological manipulation of calcium-dependent processes, possibly at the level of the demyelinated axon, can acutely facilitate central conduction of electrical impulses in some patients with clinically stable multiple sclerosis.
The abnormal evoked potentials of patients with multiple sclerosis provide evidence for deranged electrical conduction over specific demyelinated central pathways. ' Recent studies have suggested that fundamental changes in the electrical properties of the demyelinated axonal membrane result in the conduction abnormalities of blockade, slowing, and dispersion of action potentials.24 Several 
Results

VEPs
Seven of eight patients had abnormal pretreatment VEPs. Four had bilaterally absent VEPs when tested with varying size checkerboard stimuli; three had at least one prolonged P100 latency (table 1) . During verapamil infusion, the P100 latencies shortened an average of 10-15 + 5-3 ms (p < 0.05) compared to pre-infusion latency (Table 2) . In one patient, the P100 latency shortened as much as 27-2 ms during infusion (fig. 1A) . The effect of verapamil in shortening P100 latencies could still be detected 24 hours after the infusion was discontinued. In two patients (4 and 7, not included in the statistical analysis) whose PlOOs were absent prior to infusion, a poorly defined P100 peak emerged when using a large check size (1°28') during infusion ( fig. 1B) It is well established that verapamil inhibits transmembrane flux of calcium in virtually all tissues studied to date. Conceivably, verapamil could modify the ionic flux of calcium through demyelinated axonal membrane, and alter local electrical fields. This would have an effect on the sodium channel voltage sensors to alter the rate of sodium inactivation similar to subthreshold depolarization.' 10 Alternatively, verapamil could modify calciumdependent, voltage sensitive potassium channels.9 [25] [26] [27] [28] There is evidence to suggest that potassium conductance is increased in areas of demyelination compared to the normal axon.2930 An agent which blocks potassium channels directly would therefore be expected to improve the conduction block of demyelinated fibres. 3 
